source
- Biogen to acquire San Diego biotech RayThera in up to $1 billion dealBiogen announced it will acquire RayThera, a San Diego-based biotech, in a transaction valued at up to $1 billion. The agreement specifies that most of the payment will be made through milestone-b…
- RA Capital, Forbion and Sanofi Ventures back Korean eye-drug startupRA Capital, Forbion and Sanofi Ventures are reported to be providing financing for a new eye-drug company that is developing its product in Korea. The investment follows a growing pattern where la…